We are live on ! Find out more
CYTH

Cyclo Therapeutics, Inc. Common Stock

Delisted

CYTH was delisted on the 25th of March, 2025.

13 hedge funds and large institutions have $795K invested in Cyclo Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1313 (0)

42% less capital invested

Capital invested by funds: $1.38M → $795K (-$581K)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Holders
13
Holders Change
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
6
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$500K -$3.15K -1,300 -0.5%
Renaissance Technologies
2
Renaissance Technologies
New York
$126K -$28.6K -11,801 -16%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$96K
State Street
4
State Street
Massachusetts
$57K
Wells Fargo
5
Wells Fargo
California
$4K +$10 +4 +0.2%
TRCT
6
Tower Research Capital (TRC)
New York
$4K +$1.85K +762 +51%
UBS Group
7
UBS Group
Switzerland
$2K -$3.63K -1,498 -65%
Citigroup
8
Citigroup
New York
$2K -$99 -41 -3%
BlackRock
9
BlackRock
New York
$1K -$43.2K -17,841 -98%
Morgan Stanley
10
Morgan Stanley
New York
$1K -$145 -60 -12%
IA
11
IFP Advisors
Florida
$1K
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$1K